Archana Jha, Ph.D.
https://www.niams.nih.gov/es/node/13791
Archana Jha, Ph.D., is a scientific review officer in the Scientific Review Branch at NIAMS.
Displaying 321 - 340 of 1020 results
Can Bioprinted Skin Substitutes Replace Traditional Grafts for Treating Burn Injuries and Other Serious Skin Wounds?
https://www.niams.nih.gov/es/node/13806
An NIH-funded team recently showed that bioprinted skin substitutes may serve as a promising alternative to traditional skin grafts in preclinical studies.
Data Analysis: Deregulated immune cell recruitment orchestrated by FOXM1 impairs human diabetic wound healing.
https://www.niams.nih.gov/es/node/13821
This dataset includes 3 conditions: unwounded diabetic skin, diabetic non-healing wounds and diabetic healing wounds. For this analysis, we will compare non-healing vs healing diabetic wounds.
Higher Income and Longer Working Years are Linked to Better Mobility
https://www.niams.nih.gov/es/node/13831
A new study on the relationship between mobility and income has shown that better mobility was strongly associated with higher income and longer working years in adults.
NIH-FNIH Host Workshop on the Future of Regenerative Medicine and Cell-based Therapies
https://www.niams.nih.gov/es/node/13836
The NIH and FNIH will be hosting a two-day workshop on the future of regenerative medicine and cell-based therapies on November 6 and 7, 2023.
NINDS Small Business Funding Leads to New Therapy for Duchenne Muscular Dystrophy
https://www.niams.nih.gov/es/node/13846
Duchenne muscular dystrophy (DMD) is a rare form of muscular dystrophy primarily affecting young boys. ReveraGen BioPharma, a company supported by a small business grant from the National Institute of Neurological Disorders and Stroke (NINDS), has developed a new drug for DMD, a genetic muscle-wasting disease.
Data Analysis: Transcriptional signature primes human oral mucosa for rapid wound healing
https://www.niams.nih.gov/es/node/13971
This study examines gene expression in human oral and skin at baseline (unwounded; day 1) and at days 3 and 6 of healing. Given that there are 6 groups, there are a number of interesting comparisons that are possible. As an example, we provide detailed instructions to determine differences between unwounded oral vs. skin (oral day 1 vs. skin day 1).
CLINICAL
Understanding How Skin Cancer Presentation and Survival Differs by Racial and Ethnic Groups
Disparities in skin cancer presentation between races and ethnicities.
Cancer Biology
Computational Biology
Skin Biology
TRANSLATIONAL
Manual Counting Versus Artificial Intelligence in Assessing Monkeypox Lesions Using Patient Photographs
An artificial intelligence (AI) algorithm can count mpox skin lesions in patient photographs with close correlation to manual counts.
Clinical Research
Immunology
Skin Biology
TRANSLATIONAL
Neutrophil Extracellular Traps (NETs) Trigger Pathogenic Inflammation and Bone Loss in Periodontitis
Neutrophil Extracellular Traps (NETs) cause bone destruction in periodontitis lesions by triggering the IL-17/Th17 response.
Autoimmunity
Cell Biology
Clinical Research
Immunology
Molecular Biology and Biochemistry
Systems Biology
CLINICAL
The Direct Binding of Anti-Mi2 Autoantibodies to Their Antigen Is Key to the Pathogenesis of Anti-Mi2 Dermatomyositis
Dermatomyositis (DM) Patients with anti-Mi2 autoantibodies against a transcriptional repressor protein (CHD4/NuRD complex) showed severe muscle disease than other DM patients.
Clinical Research
Immunology
Muscle Biology
Sabrina Helmold Hait, Ph.D.
https://www.niams.nih.gov/es/node/14021
Sabrina Helmold Hait, Ph.D. is a Staff Scientist at the Translational Immunology Section (TIS) at NIAMS.
NIH Awards $9.7 Million to Advance the Use of All of Us Research Program Dataset
https://www.niams.nih.gov/es/node/14026
The National Institutes of Health’s All of Us Research Program and 10 partner Institutes, Centers, and Offices have funded 26 research projects to support novel analyses and tool development using All of Us’ data. The two-year awards advance impactful research in high-priority mission areas of the NIH.
Engagement with Patient Advocacy and Community Groups is Core to NIAMS’ Mission
https://www.niams.nih.gov/es/node/14036
Since joining NIAMS in 2021, I have been struck by how much our mission is driven by meaningful interactions with patient advocacy and other community groups interested in research related to bones, joints, muscles, and skin.
Dandre Thornhill, Ph.D.
https://www.niams.nih.gov/es/node/14081
Dandre Thornhill is the Chief of the NIAMS Clinical Research Operations and Management Branch (CROMB)
NIAMS’ Mariana Kaplan Named NIH Distinguished Investigator
https://www.niams.nih.gov/es/node/14086
Mariana Kaplan, M.D., a longstanding NIAMS researcher and leader, has been promoted to the title of NIH Distinguished Investigator.
Study Identifies Subtypes of Inflammation in People with Rheumatoid Arthritis
https://www.niams.nih.gov/es/node/14101
Rheumatoid arthritis (RA) is an autoimmune disease that causes joint inflammation, pain, and stiffness. There are several treatment options to control inflammation, but response to therapy varies and some people with RA never reach remission, suggesting there may be different drivers of inflammation.